Rosenberg Jared, Natarajan Jytosna, Carenter David J, Peluso Chris, Hilton Christie, Champ Colin E
Kinesiology Department, SUNY Cortland, NY, United States.
Drexel University College of Medicine, Philadelphia, PA, United States.
Sports Med Int Open. 2025 Jun 24;9:a25564182. doi: 10.1055/a-2556-4182. eCollection 2025.
Although the function movement screen (FMS) has been widely used in the general population, no study to date has used the FMS as a preparticipation screen for individuals with breast cancer (BC) engaging in an exercise regimen. Even though individuals with BC are anthropometrically similar to individuals without cancer, the lack of studies assessing the FMS in individuals with BC may potentially hinder exercise prescription. Therefore, we aim to examine the relationships of the FMS score to anthropometric biomarkers in individuals with BC before undergoing an exercise regimen. One-hundred and twelve women with BC underwent a thrice-weekly three-month dose-escalated exercise regimen utilizing multi-joint compound movements and linear progression balanced with resistance training volume to elicit hypertrophy. FMS score and anthropometric markers were assessed pre- and post-intervention. With significance set at p≤0.05, baseline FMS scores correlated significantly with all anthropometric markers, and was similar to previous studies published in non-cancer populations. However, baseline FMS scores were not associated with changes in anthropometric markers, from pre- to post-intervention. While the baseline FMS score was not associated with changes in anthropometric markers, the similar correlation found in our study compared to previous studies suggest that the FMS can be used as a preparticipation in individuals with BC to help guide the exercise regimen. Future studies designed to elicit weight loss in individuals with BC should assess whether the baseline FMS score is predictive of anthropometric changes.
尽管功能动作筛查（FMS）已在普通人群中广泛应用，但迄今为止，尚无研究将FMS用作乳腺癌（BC）患者参与运动方案的参与前筛查。尽管BC患者在人体测量学方面与非癌症患者相似，但缺乏对BC患者进行FMS评估的研究可能会阻碍运动处方的制定。因此，我们旨在研究在进行运动方案之前，BC患者的FMS评分与人体测量学生物标志物之间的关系。112名BC女性患者接受了为期三个月、每周三次、剂量递增的运动方案，该方案采用多关节复合动作和线性进展，并与抗阻训练量相平衡，以促进肌肉肥大。在干预前后评估FMS评分和人体测量指标。显著性水平设定为p≤0.05，基线FMS评分与所有人体测量指标均显著相关，且与之前在非癌症人群中发表的研究结果相似。然而，从干预前到干预后，基线FMS评分与人体测量指标的变化无关。虽然基线FMS评分与人体测量指标的变化无关，但与之前的研究相比，我们的研究发现了相似的相关性，这表明FMS可用于BC患者的参与前评估，以帮助指导运动方案。未来旨在促使BC患者体重减轻的研究应评估基线FMS评分是否可预测人体测量学变化。
